Fluoropyrimidines in Cancer Therapy 2003 Edition Contributor(s): Rustum, Youcef M. (Editor) |
|
![]() |
ISBN: 0896039560 ISBN-13: 9780896039568 Publisher: Humana OUR PRICE: $161.49 Product Type: Hardcover Published: December 2002 Annotation: Leading cancer researchers update and review the mechanisms of action and the therapeutic selectivity and efficacy of 5-FU with and without leucovorin and its prodrugs in the treatment of colorectal cancer. Among the combination agents considered are UFT/LV, 5-FU/EU, capecitabine (Xeloda), S-1, and a variety of thymidylate synthase inhibitors. The authors discuss the potential advantages and disadvantages of these varied drugs and their mode of administration. Based on historical results with these agents when used alone, they also present a rationale for their results when used in combination with other agents. |
Additional Information |
BISAC Categories: - Medical | Oncology - General - Medical | Gastroenterology - Medical | Pharmacology |
Dewey: 616.994 |
LCCN: 2002017289 |
Series: Cancer Drug Discovery & Development |
Physical Information: 0.81" H x 7" W x 10" (1.78 lbs) 326 pages |